Literature DB >> 8675601

Angiotensin II receptors and angiotensin II stimulation of ciliary activity in human fallopian tube.

E Saridogan1, O Djahanbakhch, J R Puddefoot, C Demetroulis, K Collingwood, J G Mehta, G P Vinson.   

Abstract

Using an antibody (6313/G2) directed against a specific sequence in the extracellular domain of the type 1 angiotensin II receptor (AT1), we demonstrated the presence of angiotensin II (AII) receptors in human fallopian tube. Immunoperoxidase staining for AT1 receptor showed positive staining in the epithelium of the tubal mucosa. The intensity of staining varied depending upon the hormonal status at the time of salpingectomy, being strongest in the proliferative phase of the ovarian cycle and weakest after menopause. Ligand binding assay confirmed that the AII receptor concentration was highest in the mucosa of fallopian tubes from premenopausal women. Mucosa from the ampullary segment had higher concentrations of AII receptor than the fimbrial and isthmic segments in both premenopausal and postmenopausal women. Displacement studies using specific AII receptor subtype antagonists showed that approximately 60% of the total activity could be displaced by CGP42112B (type 2 specific) and 40% by losartan (AT1 specific). Immunoblotting confirmed that the antibody detected a protein of approximately 60 kDa. Functional studies showed that AII had a stimulatory action on tubal ciliary beat frequency, but had no significant effect on myosalpingseal activity. This effect was achieved at nanomolar concentrations of AII; further increases in the AII concentration were without additional effect. The stimulatory effect of AII was inhibited by the specific AT1 antagonist losartan, whereas the type 2 antagonist, CGP42112B, had no effect. The data demonstrate that AII may play an important role in ovum transport and fertility.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675601     DOI: 10.1210/jcem.81.7.8675601

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Tubal transport of gametes and embryos: a review of physiology and pathophysiology.

Authors:  Mohammad Ezzati; Ovrang Djahanbakhch; Sara Arian; Bruce R Carr
Journal:  J Assist Reprod Genet       Date:  2014-08-13       Impact factor: 3.412

2.  Rapid effects of progesterone on ciliary beat frequency in the mouse fallopian tube.

Authors:  Anna Bylander; Magdalena Nutu; Rikard Wellander; Mattias Goksör; Håkan Billig; D G Joakim Larsson
Journal:  Reprod Biol Endocrinol       Date:  2010-05-15       Impact factor: 5.211

Review 3.  Laboratory models for studying ectopic pregnancy.

Authors:  Jeremy K Brown; Andrew W Horne
Journal:  Curr Opin Obstet Gynecol       Date:  2011-08       Impact factor: 1.927

4.  Captopril may influence tone of human oviduct ampulla.

Authors:  Slobodan M Jankovic; Snezana V Jankovic; Janko M Djuric; Marko M Folic; Isidora Stojic
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-11       Impact factor: 3.738

5.  Angiotensin II type 1 receptor expression in human breast tissues.

Authors:  E R Inwang; J R Puddefoot; C L Brown; A W Goode; S Marsigliante; M M Ho; J G Payne; G P Vinson
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer.

Authors:  Michela Coan; Gian Luca Rampioni Vinciguerra; Laura Cesaratto; Emanuela Gardenal; Riccardo Bianchet; Erik Dassi; Andrea Vecchione; Gustavo Baldassarre; Riccardo Spizzo; Milena Sabrina Nicoloso
Journal:  Int J Mol Sci       Date:  2018-08-24       Impact factor: 5.923

7.  Can the antral follicular count modulate the gene expression of bovine oviducts in Aberdeen Angus and Nelore heifers?

Authors:  Patricia Kubo Fontes; Ronaldo Luis Ereno; André Rebello Peixoto; Robson Francisco Carvalho; Wellerson Rodrigo Scarano; Luzia Aparecida Trinca; Ciro Moraes Barros; Anthony César de Souza Castilho
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.